Vetter

Pharma Provider Vetter Accelerates Switch to Renewable Energy

Vetter aims to reduce its absolute greenhouse gas emissions by 58.8% by 2034 (base year 2021). A key lever for this is the continuous switch to renewable energies.

Pharma Service Provider Vetter Establishes New Site in Chicago

Vetter broke ground for the start of construction of its new clinical site in Des Plaines, Illinois, US on June 26.

The Evolution of the CDMO Industry

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine. CHEManager asked executives and industry experts from a broad range of CDMOs to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

Expert Statement: Thomas Otto and Peter Soelkner, Vetter

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Patient Centricity: The New Nexus for CDMOs

Vetter Appoints Oliver Albrecht as Managing Director

Vetter Announces Personnel Changes in its Development Service Division

iBIO and iBIO Institute Boards Elect Andy Hull and Linda Friedman as 2014 Chairs

Vetter's Newest Facility Successfully Completes FDA Inspection